Skip to Content

Sugar-coated Medicine

January 1, 2000

DNA and proteins are the stars of biotech, but they aren’t the only prime players in biology. Recent studies show that complex sugars called polysaccharides have a critical role in cell development and tumor formation. Like DNA, these sugars are composed of basic chemical building blocks whose sequence determines their biological functions. Until now, however, sugars have remained a bit player in the biotech revolution-partly because sequencing a single polysaccharide could take months.

A new technique developed by a pair of MIT researchers, Ram Sasisekharan and Ganesh Venkataraman, could change all that, allowing sugar sequences to be deciphered in days. By getting the job done much more efficiently and quickly, the MIT approach paves the way for researchers to clarify the exact roles complex sugars play throughout the body. The potential payoff: future drugs that target sugars linked to viral infections, cancerous tumors and other diseases. “The MIT group has taken this technique to a very high level of utility,” says Merton Bernfield, a professor of cell biology at Harvard University.

Lodged between cells, polysaccharides known as glycosaminoglycans (GAGs) regulate cell-to-cell communication. These sugars are highly specialized; the arrangement of their building blocks dictates the message neighboring cells receive, and ultimately serves to differentiate organs. GAG sequences in the liver, for instance, differ substantially from those in the kidney; those in healthy tissues differ from those that are diseased. Biomedical researchers would like to be able to divide the body into unique, sugar-based “zip codes,” says Venkataraman. “Once you know these zip codes, you can distinguish between normal and abnormal tissues.”

The MIT researchers now aim to design a machine to automate the procedure. “We’re at the tip of the iceberg in the polysaccharide field, where DNA and protein research was years ago,” says Sasisekharan.

Keep Reading

Most Popular

Rendering of Waterfront Toronto project
Rendering of Waterfront Toronto project

Toronto wants to kill the smart city forever

The city wants to get right what Sidewalk Labs got so wrong.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

images created by Google Imagen
images created by Google Imagen

The dark secret behind those cute AI-generated animal images

Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.